@IktosAI

Artificial intelligence for new drug design

 Paris, France
iktos.ai
Joined April 2018
  • Tweets247
  • Following657
  • Followers1.1K
33Media
Come see @Iktos present 4/25 at @MassBio 2024 Align Summit w/ insights by @McKinsey & @LocustWalkPtrs. Register here: massbio.org/align #AlignSummit24
1
398
@IktosAI and @ElsLifeSciences are thrilled to partner together to deliver a predictive #retrosynthesis and synthetic accessibility platform that accelerates chemistry research for drug discovery. Learn more: iktos.ai/2024/03/05/iktos-an… #Reaxys #drugdiscovery #DMTAcycle #AI
1
1
2
563
Seasons greetings from @IktosAI team linkedin.com/feed/update/urn…

Iktos team wishes you all a ‘Merry Christmas’ and a ‘Happy 2023’! Thank you to all our clients,...

Iktos team wishes you all a ‘Merry Christmas’ and a ‘Happy 2023’! Thank you to all our clients, collaborators, and suppliers for their continued support in 2022. We look forward to working with you...

linkedin.com
2
3
647
@IktosAI team will be at the JPM 2023 linkedin.com/feed/update/urn…

Iktos team will be at the JPM in Jan 2023. Meet our CEO, Yann Gaston-Mathe , VP, Head of BD- EU,...

Iktos team will be at the JPM in Jan 2023. Meet our CEO, Yann Gaston-Mathe , VP, Head of BD- EU, RoW, Dr. Sree Vadlamudi and Application Scientist, Dr. Brian Atwood at JPM in San Francisco from...

linkedin.com
2
3
563
In an interview with PharmaShots, Dr. Sree Vadlamudi, Vice president, Head of Business Development EU and RoW at @IktosAI, shared his views on the role of AI in shaping the pharma & biotech industry. Read the interview here: lnkd.in/eCANthA7 linkedin.com/feed/update/urn…

LinkedIn

This link will take you to a page that’s not on LinkedIn

lnkd.in
1
2
2
Dr. Sree Vadlamudi Vadlamudi, Vice President, Head of BD- EU & RoW, Iktos, talks about ‘Using AI to foster productivity in pharmaceutical research and development’ in a blog published as a part of SLAS Europe 2022 coverage. linkedin.com/feed/update/urn…

#artificialintelligence #drugdiscovery | iktos

Dr. Sree Vadlamudi Vadlamudi, Vice President, Head of BD- EU & RoW, Iktos, talks about ‘Using AI to foster productivity in pharmaceutical research and development’ in a blog published as a part of...

linkedin.com
1
1
Our CEO & Co-Founder, Yann Gaston-Mathe's interview on Spaya™ has been published by Medicen in their 2022 report. Follow the link for the full report: lnkd.in/eMScxFA6 linkedin.com/feed/update/urn…
1
1
@IktosAI announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development. linkedin.com/feed/update/urn…

#artificialintelligence #drugdiscovery #antimalarialdrugdiscovery | iktos

Iktos announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development. Under this...

linkedin.com
1
1
@IktosAI announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development. linkedin.com/feed/update/urn…

#artificialintelligence #drugdiscovery #antimalarialdrugdiscovery | iktos

Iktos announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development. Under this...

linkedin.com
3
2
linkedin.com/feed/update/urn…
1
1
linkedin.com/posts/iktos_art…

#artificialintelligence #drugdiscovery | iktos

Are you attending SLAS 2022 AI event? Our VP, Head of BD EU, RoW, Dr. Sree Vadlamudi will be chairing the Applications session at the SLAS 2022 AI Data Pipelines for Life Sciences Symposium in...

linkedin.com
1
1
linkedin.com/posts/iktos_art…

#artificialintelligence #drugdiscovery | iktos

Iktos team will be in Heidelberg, Germany to attend the 23rd EuroQSAR conference next week. Meet our CSO, Dr. Quentin Perron and Senior Medicinal Chemist, Dr. Vinícius Barros at booth 10 to learn...

linkedin.com
1
2
linkedin.com/feed/update/urn…
1
1
linkedin.com/feed/update/urn…

#acsfall2022 #artificialintelligence #virtualreality #drugdiscovery | iktos

Iktos Application Scientist, Dr. Rohit A. will be at the Nanome booth at the American Chemical Society's #ACSFall2022 in Chicago next week. Pop by booth#948 to say hi to Rohit and the Nanome team,...

linkedin.com
2
1
linkedin.com/posts/iktos_art…

#artificialintelligence #drugdiscovery | iktos

Registrations are open for Iktos’s webinar on ‘Makya™: AI-driven de novo drug design and Multi-Parametric Optimisation’ on 13th Sept 2022. The webinar will take place in two sessions: 9 am GMT / 10...

linkedin.com
1
1
linkedin.com/feed/update/urn…

#acsfall2022 #artificialintelligence #drugdiscovery | iktos

Are you attending American Chemical Society #ACSFall2022 in Chicago next week? Meet our Application Scientist, Dr. Rohit A. there to have a chat about Iktos technology platform and #artificialintel...

linkedin.com
2
4
linkedin.com/feed/update/urn…

#artificialintelligence #drugdiscovery | iktos

New website, annual Iktos conference, latest collaborations and much more… from Iktos Take a look at our August newsletter: https://bit.ly/3zRIYLm .  Sign up to our circulation to find out what we...

linkedin.com
1
1
@IktosAI team is thrilled to announce their latest collaboration agreement with Galapagos Iktos, Makya™, Spaya™ lnkd.in/esuPvy6d
2
2
@IktosAI team is very pleased to share the news about our latest collaboration agreement with Zealand Pharma pharma to develop AI technology for peptide drug design linkedin.com/feed/update/urn…

#iktos #ai #ml #chemistry #synthesis #drugdiscovery #denovodrugdesign #peptides | iktos

Iktos team is thrilled to announce their latest  collaboration agreement with Zealand Pharma to develop AI technology for peptide drug design. Iktos, a company specialized in Artificial Intelligence...

linkedin.com
1
3
Interested to know more about Makya? Have a look at out new site iktos.ai @IktosAI , Makya™, Spaya™ linkedin.com/feed/update/urn…
1
1
Load more